Viewing Study NCT02971761

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:07 PM
Ignite Modification Date: 2026-01-17 @ 7:54 PM
Study NCT ID: NCT02971761
Status: COMPLETED
Last Update Posted: 2024-02-20
First Post: 2016-11-21
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer
Sponsor: City of Hope Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Androgen Receptor Positive View
None Estrogen Receptor Negative View
None HER2/Neu Negative View
None Metastatic Triple-Negative Breast Carcinoma View
None Progesterone Receptor Negative View
None Stage IV Breast Cancer AJCC v6 and v7 View
Keywords: